Search by Drug Name or NDC
NDC 10135-0765-10 METOLAZONE 2.5 mg/1 Details
METOLAZONE 2.5 mg/1
METOLAZONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is METOLAZONE.
MedlinePlus Drug Summary
Metolazone, is used to reduce the swelling and fluid retention caused by heart failure or kidney disease. It also is used alone or with other medications to treat high blood pressure. Metolazone is in a class of medications called diuretics ('water pills'). It causes the kidneys to reduce the amount of water and salt in the body by increasing the amount of urine.
Related Packages: 10135-0765-10Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Metolazone
Product Information
| NDC | 10135-0765 |
|---|---|
| Product ID | 10135-765_09bb313e-90cf-5629-e063-6294a90ac268 |
| Associated GPIs | |
| GCN Sequence Number | 008217 |
| GCN Sequence Number Description | metolazone TABLET 2.5 MG ORAL |
| HIC3 | R1F |
| HIC3 Description | THIAZIDE AND RELATED DIURETICS |
| GCN | 34991 |
| HICL Sequence Number | 003663 |
| HICL Sequence Number Description | METOLAZONE |
| Brand/Generic | Generic |
| Proprietary Name | METOLAZONE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metolazone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | METOLAZONE |
| Labeler Name | Marlex Pharmaceuticals, Inc. |
| Pharmaceutical Class | Increased Diuresis [PE], Thiazide-like Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216216 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0765-10 (10135076510)
| NDC Package Code | 10135-765-10 |
|---|---|
| Billing NDC | 10135076510 |
| Package | 1000 TABLET in 1 BOTTLE (10135-765-10) |
| Marketing Start Date | 2022-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |